2019 annual financial data
Travere Therapeutics 2019 Operating cash flow growth
Direct answer
Operating cash flow growth was -133.25%.
Operating income was -99,810,000 USD and net income was -146,427,000 USD.
Operating cash flow was -58,214,000 USD.
Get free Travere Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 175,338,000 USD
- Operating income
- -99,810,000 USD
- Net income
- -146,427,000 USD
- Operating cash flow
- -58,214,000 USD